Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Black Diamond Therapeutics Inc (BDTX)

Black Diamond Therapeutics Inc (BDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Black Diamond Therapeutics Inc ONE MAIN STREET 14TH FLOOR CAMBRIDGE MA 02142 USA

www. blackdiamondtherapeutics.com P: 617-252-0848

Description:

Black Diamond Therapeutics Inc. is an oncology medicine company. It engages in discovery and development of small molecule, tumor-agnostic therapies. The company's lead product candidate is BDTX-189, an inhibitor of non-canonical and oncogenic mutations of ErbB kinases epidermal growth factor receptor and tyrosine-protein kinase. Black Diamond Therapeutics Inc. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 309,402
Enterprise Value, $K 253,182
Shares Outstanding, K 52,530
Annual Sales, $ 0 K
Annual Net Income, $ -82,440 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -19,410 K
EBIT, $ -86,460 K
EBITDA, $ -86,020 K
60-Month Beta 2.64
% of Insider Shareholders 9.07%
% of Institutional Shareholders 95.47%
Float, K 47,766
% Float 90.93%
Short Volume Ratio 0.45

Growth:

1-Year Return 288.81%
3-Year Return -77.89%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.34 on 03/12/24
Latest Earnings Date 05/14/24
Earnings Per Share ttm -1.88
EPS Growth vs. Prev Qtr 24.44%
EPS Growth vs. Prev Year 42.37%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BDTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -76.43%
Return-on-Assets % -56.24%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.26
Book Value/Share 2.26
Interest Coverage -2.04
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar